3.0
2. März 2017
Aktueller Mitarbeiter, mehr als 3 Jahre
Tuas
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Big company with mature processes and systems in place. Pipeline is going to be profitable with ventures into oncology medicines
Kontras
- Very stingy to the staff and management in Singapore but splurging at other continents. - Senior is squeezing the employees till the last drop but willing to look into their welfare - Slave-driver mentality and MSD is no longer considered a good employer in the Pharmaceutical industry